NEUROENDOCRINE, GASTROINTESTINAL CANCER

Clinical trials for NEUROENDOCRINE, GASTROINTESTINAL CANCER explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE, GASTROINTESTINAL CANCER trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE, GASTROINTESTINAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for tough cancers: observing a promising Drug's Real-World impact

Disease control Recruiting now

This study aims to see how well the drug T-DXd works in real-world settings for patients with advanced HER2-positive cancers who have already tried other treatments and have no good options left. It will follow about 100 patients with various solid tumors (excluding breast, lung,…

Matched conditions: NEUROENDOCRINE, GASTROINTESTINAL CANCER

Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

NEUROENDOCRINE, GASTROINTESTINAL CANCER

Get alerted when new NEUROENDOCRINE, GASTROINTESTINAL CANCER trials appear

New hope for tough cancers: observing a promising Drug's Real-World impact